MAPK1 and neoplasm: It isn’t clear whether the therapeutic index of MEK/MAPK7 inhibitor combination will be similar or different to serial combination inhibition of the Raf/MEK/ERK pathway, which is highly effective at inhibiting tumor cell proliferation, but which is also somewhat toxic [41].